Q&A: Noninvasive liquid biopsy test could be ‘game changer’ for NASH, liver fibrosis

A noninvasive liquid biopsy test diagnosed the presence and severity of nonalcoholic steatohepatitis and liver fibrosis more reliably than liver biopsy, according to research published in Gut.In a multicenter study, researchers identified two novel protein biomarkers (PLIN2 and RAB14) that demonstrated high accuracy, sensitivity and specificity in the diagnosis of NASH and/or liver fibrosis. The proteins were tested in both primary and validation cohorts, and results were confirmed through liver biopsy. More reliable than currently used biomarkers, these proteins could aid in identifyingRead More

Related Articles